These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments. Kjellen E; Joiner MC; Collier JM; Johns H; Rojas A Radiother Oncol; 1991 Oct; 22(2):81-91. PubMed ID: 1835542 [TBL] [Abstract][Full Text] [Related]
9. [The effect of nicotinamide and carbogen on the radiation tolerance of the spinal cord of the rat]. Raabe A Strahlenther Onkol; 1994 Nov; 170(11):674-5. PubMed ID: 7974185 [No Abstract] [Full Text] [Related]
10. [Prevention of radiation injuries during multifractionation in radiation therapy]. Zholkiver KI; Zevrieva IF Med Radiol (Mosk); 1983 Apr; 28(4):3-6. PubMed ID: 6835069 [TBL] [Abstract][Full Text] [Related]
12. [The determination of the optimal irradiation dose in the tumor tissue-normal body tissues system]. Klepper LIa Med Tekh; 1997; (4):18-21. PubMed ID: 9379858 [TBL] [Abstract][Full Text] [Related]
14. Is hyperbaric oxygen more effective than carbogen/nicotinamide in tumor radiation response? Hartmann KA; Van der Kleij AJ; Schneider CJ; Sminia P Radiat Res; 1997 Nov; 148(5):523-5. PubMed ID: 9355875 [No Abstract] [Full Text] [Related]
16. [Methodic approaches using normobaric interval hypoxia and impulse magnetic field to increase nonspecific and anti-radio resistance in workers of ecologically unfavorable industries]. Ushakov IB; Izmerov NF; Bukhtiiarov IV; Dvornikov MV; Stepanov VK; Usov VM; Lobkaeva EP; Nikitina LS; Sudarev AM; Valyeva IuV; Labyntseva IuM Med Tr Prom Ekol; 2005; (2):11-5. PubMed ID: 15822341 [TBL] [Abstract][Full Text] [Related]
17. [Approximate methods for calculation of the likelihood of radiation complications. The generalized PKLQ method (GPKLQM)]. Klepper LIa Med Tekh; 2002; (5):27-32. PubMed ID: 12512280 [TBL] [Abstract][Full Text] [Related]
18. Carbogen and nicotinamide: expectations too high? Brown JM Radiother Oncol; 1992 Jun; 24(2):75-6. PubMed ID: 1386679 [No Abstract] [Full Text] [Related]
19. Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy. Anscher MS; Chen L; Rabbani Z; Kang S; Larrier N; Huang H; Samulski TV; Dewhirst MW; Brizel DM; Folz RJ; Vujaskovic Z Int J Radiat Oncol Biol Phys; 2005 May; 62(1):255-9. PubMed ID: 15850930 [TBL] [Abstract][Full Text] [Related]
20. Extrapolations from laboratory and preclinical studies for the use of carbogen and nicotinamide in radiotherapy. Rojas A; Joiner MC; Denekamp J Radiother Oncol; 1992 Jun; 24(2):123-4. PubMed ID: 1386678 [No Abstract] [Full Text] [Related] [Next] [New Search]